STEVEN CURLEY to Catheter Ablation
This is a "connection" page, showing publications STEVEN CURLEY has written about Catheter Ablation.
Connection Strength
2.867
-
Cost-effectiveness of simultaneous resection and RFA versus 2-stage hepatectomy for bilobar colorectal liver metastases. J Surg Oncol. 2014 May; 109(6):516-20.
Score: 0.318
-
Non-invasive radiofrequency ablation of malignancies mediated by quantum dots, gold nanoparticles and carbon nanotubes. Ther Deliv. 2011 Oct; 2(10):1325-30.
Score: 0.273
-
Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? Ann Surg Oncol. 2008 Jan; 15(1):11-3.
Score: 0.208
-
Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver. Arch Surg. 2006 Jun; 141(6):537-43; discussion 543-4.
Score: 0.189
-
The role of focal liver ablation in the treatment of unresectable primary and secondary malignant liver tumors. Semin Radiat Oncol. 2005 Oct; 15(4):265-72.
Score: 0.180
-
Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol. 2005 Aug; 12(8):616-28.
Score: 0.177
-
Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg. 2004 Apr; 239(4):450-8.
Score: 0.162
-
Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol. 2003 Nov; 10(9):1059-69.
Score: 0.158
-
Radiofrequency ablation of malignant liver tumors. Ann Surg Oncol. 2003 May; 10(4):338-47.
Score: 0.152
-
Complication, local recurrence, and survival rates after radiofrequency ablation for hepatic malignancies. Surg Oncol Clin N Am. 2003 Jan; 12(1):243-55.
Score: 0.149
-
Radiofrequency ablation of primary and metastatic hepatic malignancies. Int J Clin Oncol. 2002 Apr; 7(2):72-81.
Score: 0.141
-
Water-structuring molecules and nanomaterials enhance radiofrequency heating in biologically relevant solutions. Chem Commun (Camb). 2016 Oct 18; 52(85):12630-12633.
Score: 0.097
-
Prospective screening increases the detection of potentially curable hepatocellular carcinoma: results in 8,900 high-risk patients. HPB (Oxford). 2013 Dec; 15(12):985-90.
Score: 0.076
-
Radiofrequency ablation leads to excellent local tumor control and durable longterm survival in specific subsets of early stage HCC patients confirming to the Milan criteria. Ann Surg. 2010 Dec; 252(6):913-4.
Score: 0.064
-
Long-term survival after surgical management of neuroendocrine hepatic metastases. HPB (Oxford). 2010 Aug; 12(6):427-33.
Score: 0.063
-
Targeted hyperthermia using metal nanoparticles. Adv Drug Deliv Rev. 2010 Mar 08; 62(3):339-45.
Score: 0.060
-
Solitary colorectal liver metastasis: resection determines outcome. Arch Surg. 2006 May; 141(5):460-6; discussion 466-7.
Score: 0.047
-
Debunking dogma: surgery for four or more colorectal liver metastases is justified. J Gastrointest Surg. 2006 Feb; 10(2):240-8.
Score: 0.046
-
Outcomes after surgical treatment of colorectal cancer liver metastases. Semin Oncol. 2005 Dec; 32(6 Suppl 9):S109-11.
Score: 0.046
-
Transdiaphragmatic radiofrequency ablation of liver tumors. J Am Coll Surg. 2004 Nov; 199(5):826-9.
Score: 0.042
-
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004 Jun; 239(6):818-25; discussion 825-7.
Score: 0.041
-
Radiofrequency ablation: the experts weigh in. Cancer. 2004 Feb 01; 100(3):641-50.
Score: 0.040
-
Surgical treatment of colorectal cancer metastasis. Cancer Metastasis Rev. 2004 Jan-Jun; 23(1-2):165-82.
Score: 0.040
-
Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancer. Ann Surg Oncol. 2003 May; 10(4):348-54.
Score: 0.038
-
Advances in the treatment of liver tumors. Curr Probl Surg. 2002 May; 39(5):449-571.
Score: 0.036
-
Surgical treatment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford). 2010 Jun; 12(5):302-10.
Score: 0.016
-
Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol. 2004 Sep; 11(9):869-74.
Score: 0.010